5th October LDN Research Trust Webinar

Presenters

Dr Akbar Khan – The role of LDN & Natural Medicines in Infection Prevention and Therapy

Dr Kent Holtorf – COCID 19 and CPOVID Long Haulers

Kent Holtorf, MD, is the medical director of the Holtorf Medical Group(Holtorfmed.com) and founder and medical director of the non-profit National Academy of Hypothyroidism (NAHypothyroidism.org). He is also the founder of Integrative Peptides (IntegrativePeptides.com), dedicated to training physicians about ground-breaking peptide therapies and bringing doctors and patients the highest quality natural bioidentical peptides as supplements with unique delivery systems.

Dr Holtorf is an internationally known lecturer, author, and innovator in cutting-edge research and treatments. He has personally trained numerous physicians across the country in the use of bioidentical hormones, thyroid replacement for complex hypothyroidism syndromes, peptide therapies, immune-modulatory strategies, stem cell, exosome and growth factor treatment, hormone replacement for complex endocrine dysfunction, and innovative treatments of chronic fatigue syndrome, fibromyalgia, Lyme disease, and other chronic infectious diseases, CIRS, neurodegenerative diseases, and many others.

He is a fellowship lecturer for A4M. He was the Endocrinology Expert for AOL Health and is a guest editor and peer-reviewer for the medical journals Endocrine, Postgraduate Medicine, and Pharmacy Practice. Dr Holtorf has published many peer-reviewed endocrine reviews on complex, multisystem, poorly understood conditions. He has demonstrated that much of the long-held dogma in endocrinology and infectious disease is inaccurate.

He has been a featured guest on CNBC, ABC News, CNN, Fox News (debated the Fox news medical A-team), Good Morning America, The Today Show, EXTRA TV, Discovery Health, The Learning Channel, Glenn Beck, Nancy Grace, Sean Hannity, and more and quoted in numerous print media including the Wall Street Journal, Los Angeles Times, US News and World Report, San Francisco Chronicle, WebMD, Forbes, among many others.

Akbar Khan, MD, IMD, DHS, FAAO

Dr Khan is a graduate of the University of Toronto, Faculty of Medicine (1992). He completed his certification in Family Medicine in 1994. Dr Khan worked as an addiction consultant and a surgical assistant and has been active in pain and symptom management for cancer patients since 1994. Through this work he developed an interest in non-toxic cancer treatment. In 2006, Dr Khan co-founded Medicor Cancer Centres, the first integrated private cancer clinic of its kind in Canada. Since 2007, Dr Khan has gained international recognition for his work with gentle off-label drugs in cancer treatment, such as low dose naltrexone and dichloroacetate.

From 2015, Dr Khan’s focus began to shift toward disease prevention and wellness. In 2018, he received the title of “Integrative Medical Doctor” from the Board of Integrative Medicine. In the same year, Dr Khan began a program of training and certification in medical ozone therapy. Dr Khan became one of 3 physicians in Canada to have earned fellowship certification from the American Academy of Ozone Therapy. In 2019 Dr Khan founded Sano Via Wellness, a health and wellness division of his existing practice.

Dr Khan acts as a medical advisor for the LDN Research Trust and NAVCO pharmaceuticals. Dr Khan regularly publishes in peer-reviewed medical journals and has been invited to present lectures on ozone therapy, integrative cancer therapy and quality of life in cancer since 2000.